XDemics Corporation, a Caltech spinout, is fundamentally improving the way cells are grown. The production of high-quality mammalian cells remains a bottleneck, limiting productivity across the biomed
...
XM Therapeutics is a Brown University spinoff developing tissue repair and regeneration therapies for chronic disorders where an impaired healing response leads to progressive fibrosis (scarring), inf
...
Evolved from AA&sons Family Office (140 investments over 10 years in tech and healthcare).Yaday Capital: Focus on Applied AIYaday Health: Focus on convergence of Tech and Bio
Duo Oncology is an oncology company reimagining chemotherapy, a foundational treatment for metastatic cancer. Its lead program, DUO-207, consolidates multi-drug chemotherapy regimens into a single, po
...
FELIQS is targeting oxidized lipids to prevent serious ophthalmology diseases, like Retinopathy of Prematurity (ROP) and intermediate dry-AMD using small molecules.
JLS is an NY-based venture capital fund formed to invest in the exciting intersection of science, technology and neurology, leveraging the enormous potential of plant-based and psychedelic medicines t
...